Dr. Ron Najafi's videos and podcasts

Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health

Robert Lustig, MD: Everything You Know About Obesity Is Wrong

What is the latest on Ozempic and Ozempic like drugs #ozempic #glp1

Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It

Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.

The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig

Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet

Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome

Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose

Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance

Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet

Bill Wilson MD: Doctors Lack Metabolic Training. Ultra-Processed Foods Get Subsidized Over Real food

The Self-Made Immune Man: Tim Friede’s Role in Creating a Universal Antivenom for Deadly Snakebites

Bill Wilson, MD: GLP-1 Flips the Switch—Reversing Karp Syndrome by Restoring Monoamines Naturally

Sustainability in Pharma: PDA at Gilead — Emery Pharma as Major Sponsor | EcoFunnel & Green Labs

Bill Wilson, MD: GLP-1 Cuts Sugar Cravings—Breaking the Insulin Spike and Vicious Cycle of Addiction

Robert Lustig, MD: Why 5-Year-Olds Now Have the Same Liver Disease Once Seen Only in Alcoholics

Dr. Ryan Cheu | Emery Pharma Capabilities -Drug Metabolism, Metabolite ID & Bioanalysis #bioanalysis